Index Copernicus Value : 93.38
NLM ID: 101580370
Submit manuscript at https://www.scholarscentral.org/submissions/molecular-biomarkers-diagnosis.html or send as an e-mail attachment to the Editorial Office at editor@hilarisjournal.com
*2019 Journal Impact Factor was established by dividing the number of articles published in 2017 and 2018 with the number of times they are cited in 2019 based on Google Scholar Citation Index database. If 'X' is the total number of articles published in 2017 and 2018, and 'Y' is the number of times these articles were cited in indexed journals during 2019 then, journal impact factor = Y/X
Journal of Molecular Biomarkers & Diagnosis is best Open Access, online, medical journal. Biomarker is an indicator of a particular disease or physiological state of an organism. Journal of Molecular Biomarkers and diagnosis is a peer reviewed medical journal that includes a wide range of topics in this field and creates a platform for the authors to make their contribution towards the journal.
The Journal seeks high-quality submissions and welcome contributions in Biomarker, genetic marker, screening, dna-profiling, cytogenetics, transcriptome, cancer biomarkers, prostate specific antigen, biomarker toxicology. Journal of Molecular Biomarkers & Diagnosis is an Open Access scholarly journal and aims to publish most complete and reliable source of information.
This scholarly publishing is using Editorial Tracking System for quality in the review process. Editorial Tracking is an online manuscript submission, review and that tracks the review status. Review process is performed by the editorial board members of Journal of Molecular Biomarkers & Diagnosis or outside experts; at least two independent reviewer’s approval followed by the editor is required for the acceptance of any citable manuscript.
Rapid Publication Service
Hilaris Publishing is offering wide range of opportunities, options and services for the prospective authors to publish their scholarly contributions.
The journal caters to the demands of the fast publication without compromising on the editorial quality including manuscript peer-review. This flexibility is being provided to ensure earliest author credibility to their respective contributions and this will also ensure timely dissemination of research outcomes for efficient integration, effective translation and reduced redundancy.
Authors have the option to choose between the standard open access publication service which takes its own course of time for complete publication process or can opt for rapid publication service wherein the article is published at the earliest date (Includes multiple subject experts commissioning for securing earliest peer-review comments). The authors can avail this flexibility based on the personal preference, funding agency guidelines or Institutional or organizational requirements.
Regardless of the option, all manuscripts undergo thorough peer-review process, editorial assessment and production process.
Fast Editorial Execution and Review Process (FEE-Review Process)
Authors who are willing to publish their articles under this mode can make a pre-payment of $99 towards express peer-review and editorial decision. First editorial decision in 3 days and final decision with review comments in 5 days from the date of submission. Galley proof generation will be done in next 2 days from acceptance or maximum 5 days (For manuscripts notified for revision by external reviewer).
Manuscripts accepted for publication will be charged regular APC.
Authors retain the copyright of their publication and the final version of the article will be published in both HTML and PDF formats as well as XML formats for transmitting to indexing databases. The editorial team of the Journal will ensure adherence to scientific publication guidelines.
Articles published in Molecular Biomarkers & Diagnosis have been cited by esteemed scholars and scientists all around the world. Molecular Biomarkers & Diagnosis has got h-index 19 , which means every article in Molecular Biomarkers & Diagnosis has got 19 average citations.
Molecular Biomarkers & Diagnosis received 2054 citations as per Google Scholar report
Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi 